Bottles in a lab

Tcelna

Tcelna (previously known as Tovaxin) is a treatment being developed for secondary progressive and relapsing MS by Opexa Therapeutics

Current phase of trial: Phase 2

Type of MS: Secondary progressive and relapsing MS

About Tcelna